Redrawing the biopharma map: India’s rise in the biosimilars era
For India’s biopharma sector, 2025 stood out as an inflection point. The approval of 146 recombinant biosimilar therapeutic…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
biopharma
BIOLOGICS X 3DCC 2026 concludes successfully, advancing India’s vision for next-gen biopharma…
Biologics X 3DCC 2026, a unified platform combining the Sixth Edition of the Annual Summit on Biopharmaceutical Product…
Industry calls Union Budget 2026 a defining moment for India’s biopharma future
Industry stakeholders view the Union Budget 2026 as a pivotal inflection point in India’s life sciences journey. With the launch…
Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center
Cytiva, a Danaher company and a leader in the life sciences industry, is collaborating with Veeda Lifesciences (Veeda Clinical…
India’s biopharma industry charts the road from biosimilars to innovation
Express Pharma hosted the maiden Biopharma Leadership Conclave 2025 and brought together industry leaders to discuss how India can…
India is potentially on track to becoming a $300 billion bioeconomy
To understand the landscape better, how big is biopharma in India? Where are we headed, and what role does Thermo Fisher play in…
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in…
The centre brings together advanced lab technologies, expert training, and regulatory-ready workflows to help researchers,…
Top 20 biopharma companies see 7.9% increase in aggregate revenue in 2024: GlobalData
Seven out of the top 20 companies registered over 10 per cent YoY revenue growth from 2023 to 2024
CDC’s vaccine advisory committee overhaul raises concerns for vaccine oversight: GlobalData
GlobalData reveals that ADCs are expected to emerge as the fastest-growing category of medicines in the innovation pipeline for…
Biological E, Recbio collaborate to produce HPV9 vaccine
Recbio to complete technology transfer while BE will manufacture HPV9 vaccine for India, UNICEF and PAHO tender markets